Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Technology
E-136-2018
Patent ID
E-136-2018-1-CH-14
Country
CH
Application Type
EP
Patent Status
Issued
Patent Number
Publication Number
3417294
Application Number
17753704.0
IC
NCI
Date Filed
Date Issued
Patent PDF